1. Home
  2. CTOR vs TLSA Comparison

CTOR vs TLSA Comparison

Compare CTOR & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTOR
  • TLSA
  • Stock Information
  • Founded
  • CTOR 2021
  • TLSA 2013
  • Country
  • CTOR United States
  • TLSA United Kingdom
  • Employees
  • CTOR N/A
  • TLSA N/A
  • Industry
  • CTOR
  • TLSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTOR
  • TLSA Health Care
  • Exchange
  • CTOR NYSE
  • TLSA Nasdaq
  • Market Cap
  • CTOR 89.9M
  • TLSA 87.8M
  • IPO Year
  • CTOR N/A
  • TLSA 2000
  • Fundamental
  • Price
  • CTOR $1.25
  • TLSA $0.79
  • Analyst Decision
  • CTOR Strong Buy
  • TLSA
  • Analyst Count
  • CTOR 2
  • TLSA 0
  • Target Price
  • CTOR $4.50
  • TLSA N/A
  • AVG Volume (30 Days)
  • CTOR 68.9K
  • TLSA 1.1M
  • Earning Date
  • CTOR 02-14-2025
  • TLSA 02-25-2025
  • Dividend Yield
  • CTOR N/A
  • TLSA N/A
  • EPS Growth
  • CTOR N/A
  • TLSA N/A
  • EPS
  • CTOR N/A
  • TLSA N/A
  • Revenue
  • CTOR N/A
  • TLSA N/A
  • Revenue This Year
  • CTOR N/A
  • TLSA N/A
  • Revenue Next Year
  • CTOR N/A
  • TLSA N/A
  • P/E Ratio
  • CTOR N/A
  • TLSA N/A
  • Revenue Growth
  • CTOR N/A
  • TLSA N/A
  • 52 Week Low
  • CTOR $0.85
  • TLSA $0.41
  • 52 Week High
  • CTOR $49.00
  • TLSA $1.74
  • Technical
  • Relative Strength Index (RSI)
  • CTOR N/A
  • TLSA 56.56
  • Support Level
  • CTOR N/A
  • TLSA $0.65
  • Resistance Level
  • CTOR N/A
  • TLSA $0.70
  • Average True Range (ATR)
  • CTOR 0.00
  • TLSA 0.05
  • MACD
  • CTOR 0.00
  • TLSA 0.01
  • Stochastic Oscillator
  • CTOR 0.00
  • TLSA 100.00

About CTOR CITIUS ONCOLOGY INC

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: